GRACEcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.

Case-based discussion with multiple lung cancer experts on optimal treatment of a patient with advanced lung adenocarcinoma, EGFR mutation, & now acquired resistance to EGFR TKI after very good prior response.

Direct download: GRACEcast-088_Lung-Audio_CCILC_Acquired_Resistance.mp3
Category:Lung-Cancer-Audio -- posted at: 10:21am PST

Case-based discussion with multiple lung cancer experts on optimal treatment of a patient with advanced lung adenocarcinoma, EGFR mutation, & now acquired resistance to EGFR TKI after very good prior response.

Direct download: GRACEcast-088_Lung-Video_CCILC_Acquired_Resistance.m4v
Category:Lung-Cancer-Video -- posted at: 10:17am PST

Dr. David Yankelevitz, Professor of Radiology at Mount Sinai Medical Center in New York City, reviews technical advances in CT screening for lung nodules, features  suggesting whether a nodule is benign or malignant, and the CT-guided biopsy procedure.

Direct download: GRACEcast-087_Lung-Audio_Yankelevitz_on_Lung_Nodules.mp3
Category:Lung-Cancer-Audio -- posted at: 10:49pm PST

Dr. David Yankelevitz, Professor of Radiology at Mount Sinai Medical Center in New York City, reviews technical advances in CT screening for lung nodules, features  suggesting whether a nodule is benign or malignant, and the CT-guided biopsy procedure.

Direct download: GRACEcast-087_Lung-Video_Yankelevitz_on_Lung_Nodules.m4v
Category:Lung-Cancer-Video -- posted at: 10:43pm PST

Drs. Ben Solomon (Peter MacCallum Cancer Center in Melbourne) and Ross Camidge (Univ. of Colorado) answer Qs on ALK rearrangements and crizotinib (XALKORI) for advanced non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-086_Lung-Audio_Solomon_Camidge_ALK_QnA.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PST

Drs. Ben Solomon (Peter MacCallum Cancer Center in Melbourne) and Ross Camidge (Univ. of Colorado) answer Qs on ALK rearrangements and crizotinib (XALKORI) for advanced non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-086_Lung-Video_Solomon_Camidge_ALK_QnA.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PST

Dr. Ross Camidge reviews considerations of who to screen for an ALK rearrangement and additional treatment alternatives for patients with ALK-positive advanced non-small cell lung cancer.

Direct download: GRACEcast-085_Lung-Audio_Camidge_on_ALK-Positive.mp3
Category:Lung-Cancer-Audio -- posted at: 5:30pm PST

Dr. Ross Camidge reviews considerations of who to screen for an ALK rearrangement and additional treatment alternatives for patients with ALK-positive advanced non-small cell lung cancer.

Direct download: GRACEcast-085_Lung-Video_Camidge_on_ALK-Positive.m4v
Category:Lung-Cancer-Video -- posted at: 5:29pm PST

Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.

Direct download: GRACEcast-084_Lung-Audio_Solomon_on_ALK_Inhibition.mp3
Category:Lung-Cancer-Audio -- posted at: 11:49pm PST

Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.

Direct download: GRACEcast-084_Lung-Video_Solomon_on_ALK_Inhibition.m4v
Category:Lung-Cancer-Video -- posted at: 11:48pm PST

Dr. Rogerio Lilenbaum, lung cancer expert, medical oncologist, & Chairman of Cleveland Clinic Florida, answers questions on special management considerations for elderly and frail patients with lung cancer.

Direct download: GRACEcast-083_Lung-Video_Lilenbaum_Elderly_QnA.m4v
Category:Lung-Cancer-Video -- posted at: 4:25pm PST

Dr. Rogerio Lilenbaum, lung cancer expert, medical oncologist, & Chairman of Cleveland Clinic Florida, answers questions on special management considerations for elderly and frail patients with lung cancer.

Direct download: GRACEcast-083_Lung-Audio_Lilenbaum_Elderly_QnA.mp3
Category:Lung-Cancer-Audio -- posted at: 4:22pm PST

Dr. Rogerio Lilenbaum, medical oncologist and Chair of Heme/Onc at Cleveland Clinic in Weston, FL, reviews evidence on how age and other medical problems should be incorporated into management of lung cancer.

Direct download: GRACEcast-082_Lung-Audio_Lilenbaum_on_Elderly_Treatment.mp3
Category:Lung-Cancer-Audio -- posted at: 1:18am PST

Dr. Rogerio Lilenbaum, medical oncologist and Chair of Heme/Onc at Cleveland Clinic in Weston, FL, reviews evidence on how age and other medical problems should be incorporated into management of lung cancer.

Direct download: GRACEcast-082_Lung-Video_Lilenbaum_on_Elderly_Treatment.m4v
Category:Lung-Cancer-Video -- posted at: 1:15am PST

Dr. Mario Lacouture, expert dermatologist at Memorial Sloan-Kettering Cancer Center in NYC,  answers questions on management of side effects related to skin, hair, and nails for patients on cancer treatments that cause dermatologic complications.

Direct download: GRACEcast-081_CA-Rx-Audio_Lacouture_Skin_QnA.mp3
Category:Lung-Cancer-Audio -- posted at: 7:17pm PST

Dr. Mario Lacouture, expert dermatologist at Memorial Sloan-Kettering Cancer Center in NYC,  answers questions on management of side effects related to skin, hair, and nails for patients on cancer treatments that cause dermatologic complications.

Direct download: GRACEcast-081_CA-Rx-Video_Lacouture_Skin_QnA.m4v
Category:Lung-Cancer-Video -- posted at: 7:16pm PST

Dr. Mario Lacouture, expert dermatologist at Memorial Sloan-Kettering Cancer Center in NYC, reviews management of side effects related to skin, hair, and nails for patients on treatments for cancer treatments that cause dermatologic complications.


Dr. Mario Lacouture, expert dermatologist at Memorial Sloan-Kettering Cancer Center in NYC, reviews management of side effects related to skin, hair, and nails for patients on treatments for cancer treatments that cause dermatologic complications.


Case-based discussion with multiple lung cancer experts on the controversial question of whether to recommend consolidation chemotherapy after concurrent chemotherapy and radiation for locally advanced NSCLC.

Direct download: GRACEcast-079_Lung-Audio_CCILC_Unresectable_NSCLC.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PST

Case-based discussion with multiple lung cancer experts on the controversial question of whether to recommend consolidation chemotherapy after concurrent chemotherapy and radiation for locally advanced NSCLC.

Direct download: GRACEcast-079_Lung-Video_CCILC_Unresectable_NSCLC.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PST

Question and answer session with Drs. Mary Pinder-Schenck from Moffitt Cancer Center in Tampa and Nasser Hanna from Indiana University about highlights in lung cancer from ASCO 2011 annual meeting.

Direct download: GRACEcast-078_Lung-Audio_ASCO_2011_Highlights_QnA.mp3
Category:Lung-Cancer-Audio -- posted at: 3:01pm PST

Question and answer session with Drs. Mary Pinder-Schenck from Moffitt Cancer Center in Tampa and Nasser Hanna from Indiana University about highlights in lung cancer from ASCO 2011 annual meeting.

Direct download: GRACEcast-078_Lung-Video_ASCO_2011_Highlights_QnA.m4v
Category:Lung-Cancer-Video -- posted at: 3:01pm PST

Dr. Nasser Hanna from Indiana University Cancer Center reviews highlights of presentations on advanced/metastatic NSCLC from the ASCO 2011 annual meeting.

Direct download: GRACEcast-077_Lung-Audio_ASCO_2011_Highlights_2.mp3
Category:Lung-Cancer-Audio -- posted at: 2:04pm PST

Dr. Nasser Hanna from Indiana University Cancer Center reviews highlights of presentations on advanced/metastatic NSCLC from the ASCO 2011 annual meeting.

Direct download: GRACEcast-077_Lung-Video_ASCO_2011_Highlights_2.m4v
Category:Lung-Cancer-Video -- posted at: 2:04pm PST

Dr. Mary Pinder-Schenck from the H. Lee Moffitt Cancer Center in Tampa, FL reviews highlights of presentations on small cell lung cancer, early stage non-small cell lung cancer, and mesothelioma from the ASCO 2011 meeting.

Direct download: GRACEcast-076_Lung-Audio_ASCO_2011_Highlights.mp3
Category:Lung-Cancer-Audio -- posted at: 8:31pm PST

Dr. Mary Pinder-Schenck from the H. Lee Moffitt Cancer Center in Tampa, FL reviews highlights of presentations on small cell lung cancer, early stage non-small cell lung cancer, and mesothelioma from the ASCO 2011 meeting.

Direct download: GRACEcast-076_Lung-Video_ASCO_2011_Highlights.m4v
Category:Lung-Cancer-Video -- posted at: 8:30pm PST

Case-based discussion with multiple lung cancer experts on the optimal treatment of a patient with multi-station N2 node-positive squamous cell NSCLC, including whether surgery should be pursued.

Direct download: GRACEcast-075_Lung-Audio_CCILC_Node-Positive_NSCLC.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PST

Case-based discussion with multiple lung cancer experts on the optimal treatment of a patient with multi-station N2 node-positive squamous cell NSCLC, including whether surgery should be pursued.

Direct download: GRACEcast-075_Lung-Video_CCILC_Node-Positive_NSCLC.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PST

Case-based discussion with multiple lung cancer experts on whether to recommend post-operative (adjuvant) chemotherapy for a patient with a less than 4 cm non-small cell lung cancer (NSCLC) tumor with some high risk features.

Direct download: GRACEcast-074_Lung-Audio_CCILC_Node-Negative_NSCLC.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PST

Case-based discussion with multiple lung cancer experts on whether to recommend post-operative (adjuvant) chemotherapy for a patient with a less than 4 cm non-small cell lung cancer (NSCLC) tumor with some high risk features.

Direct download: GRACEcast-074_Lung-Video_CCILC_Node-Negative_NSCLC.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PST

Case-based discussion with multiple lung cancer experts on whether to recommend post-operative (adjuvant) chemotherapy for a patient with small non-small cell lung cancer (NSCLC) tumor with satellite lesions.

Direct download: GRACEcast-073_Lung-Audio_CCILC_Satellite_Nodules.mp3
Category:Lung-Cancer-Audio -- posted at: 2:17pm PST

Case-based discussion with multiple lung cancer experts on whether to recommend post-operative (adjuvant) chemotherapy for a patient with small non-small cell lung cancer (NSCLC) tumor with satellite lesions.

Direct download: GRACEcast-073_Lung-Video_CCILC_Satellite_Nodules.m4v
Category:Lung-Cancer-Video -- posted at: 2:14pm PST

Question and answer session with Dr. Minesh Mehta, Professor of Radiation Oncology at Northwestern University, on topics related to treatments for brain metastases and related complications, especially in the setting of lung cancer.

Direct download: GRACEcast-072_Lung-Video_Mehta_on_Brain_Mets_QnA.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PST

Question and answer session with Dr. Minesh Mehta, Professor of Radiation Oncology at Northwestern University, on topics related to treatments for brain metastases and related complications, especially in the setting of lung cancer.

Direct download: GRACEcast-072_Lung-Audio_Mehta_on_Brain_Mets_QnA.mp3
Category:Lung-Cancer-Audio -- posted at: 12:11am PST

Dr. Minesh Mehta, Professor of Radiation Oncology at Northwestern University, describes benefits and risks of multiple interventions that are currently used or being studied to reduce risk of developing brain metastases or treat established metastases.

Direct download: GRACEcast-071_Lung-Audio_Mehta_on_Brain_Metastases.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PST

Dr. Minesh Mehta, Professor of Radiation Oncology at Northwestern University, describes benefits and risks of multiple interventions that are currently used or being studied to reduce risk of developing brain metastases or treat established metastases.

Direct download: GRACEcast-071_Lung-Video_Mehta_on_Brain_Metastases.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PST

Dr. Lecia Sequist of Massachusetts General Hospital answers questions about acquired resistance to EGFR tyrosine kinase inhibitors and repeat biopsies of tumors over the course of treatment for advanced NSCLC.

Direct download: GRACEcast-070_Lung-Audio_Sequist_EGFR_TKI_QnA.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PST

Dr. Lecia Sequist of Massachusetts General Hospital answers questions about acquired resistance to EGFR tyrosine kinase inhibitors and repeat biopsies of tumors over the course of treatment for advanced NSCLC.

Direct download: GRACEcast-070_Lung-Video_Sequist_EGFR_TKI_QnA.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PST

Dr. Lecia Sequist of Massachusetts General Hospital describes the results of their experience in repeating biopsies in patients over the course of their ongoing treatment for advanced NSCLC and the changes in tumor characteristics over time.

Direct download: GRACEcast-069_Lung-Video_Sequist_on_Re-Biopsying_Results.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PST

Dr. Lecia Sequist of Massachusetts General Hospital describes the results of their experience in repeating biopsies in patients over the course of their ongoing treatment for advanced NSCLC and the changes in tumor characteristics over time.

Direct download: GRACEcast-069_Lung-Audio_Sequist_on_Re-Biopsying_Results.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PST

Dr. Lecia Sequist of Massachusetts General Hospital presents a summary of the challenge of acquired resistance to EGFR tyrosine kinase inhibitors like Tarceva (erlotinib) and Iressa (gefitinib), along with emerging ideas for overcoming it.

Direct download: GRACEcast-068_Lung-Video_Sequist_on_EGFR_Resistance.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PST

Dr. Lecia Sequist of Massachusetts General Hospital presents a summary of the challenge of acquired resistance to EGFR tyrosine kinase inhibitors like Tarceva (erlotinib) and Iressa (gefitinib), along with emerging ideas for overcoming it.

Direct download: GRACEcast-068_Lung-Audio_Sequist_on_EGFR_Resistance.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PST